Ipca slumps after US import alert, ripple effect fears
This article was originally published in Scrip
Executive Summary
Shares of Ipca Laboratories fell sharply following news of an FDA import alert against the company's active pharmaceutical ingredients (APls) unit in Ratlam and concerns on whether other international regulators may follow suit.